Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Cartagena
Clinical trial register · Spain

Clinical Trials in Cartagena, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 3238 Madrid 3046 Valencia 1215 Seville 1054 Málaga 746
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Hospital General Universitario Santa Lucia2 European Organisation for Research and Treatment of Cancer - EORTC2 AbbVie2 Laboratoires Arkopharma1 Hospital Universitario de Valme1
Site location
Barcelona3238 Madrid3046 Valencia1215 Seville1054 Málaga746
All 453 locations
Target enrolment
to

Trials with a site in Cartagena

25 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Not yet open
Chiesi Farmaceutici S.p.A.
Phase 3
700
Badalona, Barcelona, Cartagena, Jerez de la Frontera, Madrid, Santiago de Compostela, Valencia
2026-11-16
Recruiting
SMARTwatch for the Diagnosis of ST-segment Elevation Myocardial Infarction in Patients With Chest Pain
NCT07780942STEMI - ST-segment Elevation Myocardial Infarction, Chest Pain
Hospital General Universitario Santa Lucia
Observational
100
Cartagena
2026-08-14
Recruiting
Air Liquide Healthcare Spain
Observational
80
Cartagena, Murcia
2026-04-22
Recruiting
AbbVie
Observational
103
Málaga, Palma, Badalona, Santander, Cartagena, Gijón, Seville, Almería
2025-11-17
Recruiting
University of Campania Luigi Vanvitelli
Phase 3
480
Barcelona, Cartagena, Córdoba, Granada, L'Hospitalet de Llobregat, Madrid, Málaga, Pamplona
2025-10-01
Recruiting
AbbVie
Observational
700
Málaga, León, Cartagena, El Palmar, Murcia, Pontevedra, Toledo
2025-09-09
By invitation
Novo Nordisk A/S
Observational
1,250
Barcelona, Cartagena, Castilleja de la Cuesta, El Palmar (Murcia), Ferrol, Getafe (Madrid), La Cuesta (Santa Cruz de Tenerife), Las Palmas de Gran Canaria
2025-05-01
Recruiting
Laboratoires Arkopharma
Not applicable
207
Madrid, Cartagena, Mazarrón
2025-04-20
Active, closed
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Phase 4
120
Elche, Villajoyosa, Cartagena, Lorca, Murcia, Pozo-Aledo
2025-03-03
Recruiting
Hospital Universitario de Valme
Observational
9,000
Almería, Cadiz, Cartagena, Córdoba, Cuenca, Elche, Granada, Huelva
2025-01-01
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,082
Elche, Badalona, Centelles, Barcelona, A Coruña, Cartagena, Madrid, Seville
2024-12-02
Recruiting
Hospital General Universitario Santa Lucia
Not applicable
130
Cartagena
2024-10-07
Recruiting
Integrated Approach in Frail Older People with Atrial Fibrillation
NCT06775028Atrial Fibrillation (AF), Hypertension, Coronary Arterial Disease (CAD), Heart Failure
Heart Care Foundation
Not applicable
1,250
Alicante, Cartagena, Cártama, Elche, Málaga, Murcia, Sant Joan d'Alacant, Tarragona
2024-04-11
Active, closed
Bristol-Myers Squibb
Phase 2
100
Barcelona, Cartagena, Badalona, Cantabria, San Pedro Alcántara, Málaga, Seville
2023-11-06
Recruiting
University of Malaga
Not applicable
195
Almería, Barcelona, Granada, Madrid, Cartagena, Málaga
2023-05-05
Active, closed
Assistance Publique - Hôpitaux de Paris
Phase 3
800
Badalona, Barcelona, Cartagena, Galdakao, Madrid, Seville, Valencia
2021-08-04
Recruiting
Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites
NCT04435990Rhinitis, Allergic, Rhinoconjunctivitis, Asthma, Allergic
Inmunotek S.L.
Phase 3
150
Santiago de Compostela, Elche, Torrevieja, Valencia, Algeciras, Jerez de la Frontera, Cartagena, Vigo
2020-10-06
Recruiting
Institut Cancerologie de l'Ouest
Observational
300
Cadiz, Cartagena, Granada, Ourense, Seville, Valencia
2020-07-10
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Observational
2,000
Badalona, Barcelona, Cartagena, Córdoba, Madrid, Pamplona, Salamanca, Terrassa
2019-06-24
Active, closed
Concordance Between FFR and iFR for the Assessment of Intermediate Lesions in the Left Main Coronary Artery. A Prospective Validation of a Default Value for iFR
NCT03767621Coronary Artery Disease, Left Main Coronary Artery Stenosis, Left Main Coronary Artery Disease, Restenosis, Coronary
Fundación EPIC
Observational
300
Terrassa, Cartagena, El Palmar, Castellon, Galdakao, Albacete, Badajoz, Badalona
2019-02-19
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
885
Alcorcón, Barcelona, Bilbao, Cartagena, Córdoba, Las Palmas de Gran Canaria, Pamplona, Sabadell
2017-09-25
Recruiting
Registry for Patients With X-Linked Hypophosphatemia
NCT03193476X-Linked Hypophosphatemia
Kyowa Kirin Pharmaceutical Development Ltd
Observational
1,489
Barakaldo, Barcelona, Cartagena, El Palmar, Esplugues de Llobregat, Las Palmas de Gran Canaria, Madrid, Oviedo
2017-09-12
Active, closed
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)
NCT02864992Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV
DrugTepotinib
EMD Serono Research & Development Institute, Inc.
Phase 2
337
Barcelona, Cartagena, Jerez de la Frontera, Madrid, Málaga, San Sebastián de los Reyes, Sant Cugat del Vallès, Seville
2016-09-13
Active, closed
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Phase 2
50
Barcelona, Terrassa, Burgos, Alcorcón, Madrid, Cartagena, Marbella, Seville
2016-05-18
Recruiting
Patient Retrospective Outcomes (PRO)
NCT01550575Chronic Pain
Boston Scientific Corporation
Observational
15,000
Barcelona, Cadiz, Cartagena, Las Palmas, Logroño, Madrid, Majadahonda, Ourense
2012-04-03
Rows per page Showing 1–25 of 25
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-spain/city/cartagena

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 25 of those studies with a site in Cartagena.

How many clinical trials are recruiting in Cartagena?

16 of the 25 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 7 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Cartagena), 25 studies
PhaseStudiesRecruitingShare
Observational11944%
Phase 36324%
Not applicable4416%
Phase 23012%
Phase 4104%

Most active sponsors

Lead sponsors with the most studies (Cartagena)
Lead sponsorStudiesRecruiting
AbbVie22
European Organisation for Research and Treatment of Cancer - EORTC21
Hospital General Universitario Santa Lucia22
Air Liquide Healthcare Spain11
Assistance Publique - Hôpitaux de Paris10
Boston Scientific Corporation11
Bristol-Myers Squibb10
Chiesi Farmaceutici S.p.A.10
EMD Serono Research & Development Institute, Inc.10
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.